Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris J Rose

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Pathology Informatics|June 15, 2013
A statistical framework for analyzing hypothesized interactions between cells imaged using multispectral microscopy and multiple immunohistochemical markersChris J Rose, Khimara Naidoo, Vanessa Clay, et al.
Magnetic Resonance in Medicine|October 20, 2015
Improved accuracy and precision of tracer kinetic parameters by joint fitting to variable flip angle and dynamic contrast enhanced MRI dataBen R Dickie, Anita Banerji, Lucy E Kershaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2014
Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcomeJames P B O'Connor, Chris J Rose, John C Waterton, et al.
Radiology|February 1, 2008
Glandular function in Sjögren syndrome: assessment with dynamic contrast-enhanced MR imaging and tracer kinetic modeling--initial experienceCaleb Roberts, Geoff J M Parker, Chris J Rose, et al.
Magnetic Resonance in Medicine|May 14, 2013
Indexed distribution analysis for improved significance testing of spatially heterogeneous parameter maps: application to dynamic contrast-enhanced MRI biomarkersChris J Rose, James P B O'Connor, Tim F Cootes, et al.
British Journal of Cancer|April 28, 2017
The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant K<sup>trans</sup> in cervical cancer is explained by plasma flow rather than vessel permeabilityBen R Dickie, Chris J Rose, Lucy E Kershaw, et al.
British Journal of Cancer|October 7, 2015
Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3(+) Tregs in follicular lymphomaLilli S Nelson, James R Mansfield, Roslyn Lloyd, et al.
European Radiology|February 10, 2009
Tumour enhancing fraction (EnF) in glioma: relationship to tumour gradeSamantha J Mills, Calvin Soh, James P B O'Connor, et al.
Magnetic Resonance in Medicine|May 26, 2009
Quantifying spatial heterogeneity in dynamic contrast-enhanced MRI parameter mapsChris J Rose, Samantha J Mills, James P B O'Connor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Enhancing fraction predicts clinical outcome following first-line chemotherapy in patients with epithelial ovarian carcinomaJames P B O'Connor, Gordon C Jayson, Alan Jackson, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Pathology Informatics|June 15, 2013
A statistical framework for analyzing hypothesized interactions between cells imaged using multispectral microscopy and multiple immunohistochemical markersChris J Rose, Khimara Naidoo, Vanessa Clay, et al.
Magnetic Resonance in Medicine|October 20, 2015
Improved accuracy and precision of tracer kinetic parameters by joint fitting to variable flip angle and dynamic contrast enhanced MRI dataBen R Dickie, Anita Banerji, Lucy E Kershaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2014
Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcomeJames P B O'Connor, Chris J Rose, John C Waterton, et al.
Radiology|February 1, 2008
Glandular function in Sjögren syndrome: assessment with dynamic contrast-enhanced MR imaging and tracer kinetic modeling--initial experienceCaleb Roberts, Geoff J M Parker, Chris J Rose, et al.
Magnetic Resonance in Medicine|May 14, 2013
Indexed distribution analysis for improved significance testing of spatially heterogeneous parameter maps: application to dynamic contrast-enhanced MRI biomarkersChris J Rose, James P B O'Connor, Tim F Cootes, et al.
British Journal of Cancer|April 28, 2017
The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant K<sup>trans</sup> in cervical cancer is explained by plasma flow rather than vessel permeabilityBen R Dickie, Chris J Rose, Lucy E Kershaw, et al.
British Journal of Cancer|October 7, 2015
Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3(+) Tregs in follicular lymphomaLilli S Nelson, James R Mansfield, Roslyn Lloyd, et al.
European Radiology|February 10, 2009
Tumour enhancing fraction (EnF) in glioma: relationship to tumour gradeSamantha J Mills, Calvin Soh, James P B O'Connor, et al.
Magnetic Resonance in Medicine|May 26, 2009
Quantifying spatial heterogeneity in dynamic contrast-enhanced MRI parameter mapsChris J Rose, Samantha J Mills, James P B O'Connor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Enhancing fraction predicts clinical outcome following first-line chemotherapy in patients with epithelial ovarian carcinomaJames P B O'Connor, Gordon C Jayson, Alan Jackson, et al.
Pageof 2